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Fanconi  anemia  (FA)  is  a  rare  genetically  heterogeneous  disease 
characterized by developmental abnormalities, progressive bone marrow failure, 
and  cancer  susceptibility.  We  examined  spontaneous,  diepoxybutane  (DEB)-
induced  and  radiation-induced  sister  chromatid  exchanges  (SCEs)  in  whole-
blood  lymphocyte  cultures  of  bone  marrow  failure  (BMF)  patients  including 
Fanconi anemia, mothers of affected individuals, and healthy controls. The base-
line  frequency  of  SCE  in  FA  cells  was  similar  to  that  observed  in  controls. 
However, in response to DEB SCE frequencies in FA patients and their mothers 
were significantly increased compared to both non-FA BMF families and healthy 
controls. In response to ionizing radiation, cells displayed increased frequency of 
SCE, but no differences between FA patients and non-FA BMF patients were 
seen.  Our  data  confirm  and  expand  previous  findings  by  showing  that  SCE 
induced  by  DEB  can  be  used  as  an  adjunct  diagnostic  test  not  only  for  FA 
patients, but also for female heterozygous carriers, at least for complementation 
groups FANCA and FANCD2.  
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INTRODUCTION 
The Fanconi anemia (FA) molecular network consists of at least 15 FANC proteins 
identified thus far (HUCL and GALLMEIER, 2011). Studies on their functions revealed their main 
role in protecting against genotoxic stress by forming complexes with each other. However, all 
that proteins also participate in survival signaling pathways in hematopoietic and germ cells, and 
that second function does not necessarily require the nuclear complex formation. At least four 
FANC proteins (FANCA, FANCC, FANCG and FANCD2) have dual roles in distinct cellular 
pathways that respond to replication fork damage and oxidative stress (KONTOU et al., 2003; 
MUKHOPADHYAY et al., 2006; WILLERS et al., 2008). 
FA  is  characterized  by  variability  of  clinical  phenotypes  (JOENJE  and  PATEL,  2001; 
YAMASHITA and NAKAHATA, 2001), but the common, historically known feature associated with 
FA mutation is marked chromosomal instability (GRANT  et al., 2005) manifested as chromatid 
breaks and chromatid exchanges (SCHROEDER et al., 1964). About 10 years after the discovery of 
spontaneous  chromosomal  instability  as  cytogenetic  hallmark  of  FA,  Sasaki  and  Tonomura 
(SASAKI and TONOMURA, 1973) showed its association with a high rate of induced chromosomal 
aberrations after treatment with DNA cross-linking agents, such as  diepoxybutane (DEB)  or 
mitomycin C (MMC). As the management of patients with FA differs from that of idiopathic 
bone  marrow  failure (BMF)  syndromes,  it  is  essential  to differentiate  these  disorders at  the 
earliest. The determination of cellular sensitivity towards DEB still serves as a gold standard for 
the diagnosis and exclusion of Fanconi anemia. 
During  the  last  decade,  several  in  vitro  assays  have  been  developed  to  facilitate 
diagnosis of FA (LESKOVAC et al., 2010; JOKSIC et al., 2012). It is known that FA heterozygotes 
cannot be detected by the DEB test because their results are within the normal range (AUERBACH, 
2003). Similar to that, Mohseni-Meybodi et al. (MOHSENI-MEYBODI et al., 2007) underlined that 
differentiation between obligate carriers and the control group, based on chromosomal aberration 
analysis after MMC treatment and gamma irradiation is impossible. On the contrary, Barquinero 
et al. (BARQUINERO et al., 2001) reported significantly higher incidence of bleomycin-induced 
chromatid  breaks  in  G2  lymphocytes  of  FA  heterozygotes.  Besides  metaphase  analysis 
(AUERBACH, 2003), sensitivity of FA cells to cross-linking agents or ionizing radiation usually 
was determined using cell cycle examination (SEYSCHAB et al., 1995), comet assay (DJUZENOVA 
and FLENTJE, 2002), etc. 
The  sister  chromatid  exchange  (SCE)  analysis  is  used  extensively  to  evaluate  the 
presence  and  extent  of  chromosomal  damage  in  human  populations  (TUCKER  and  PRESTON, 
1996). Moreover, SCE is much more sensitive as a mutagenic biomarker than chromosomal 
aberrations and micronuclei (CINKILIC et al., 2009). Spontaneous SCE frequencies are believed 
to be normal in FA patients, but studies on induced SCE have yielded conflicting results. Some 
studies using DEB found no considerable changes in SCE levels in FA cells (PORFIRIO et al., 
1983; GEBHART et al., 1985), but example of increased level induced by MMC is also noted 
(MIURA et al., 1983). However, it is worth noting that DEB and MMC differ in the mechanisms 
underlying  their  toxicity  (PAGANO  and  KORKINA,  2000).  In  addition,  most  of  the  studies 
involving  sensitivity  of  FA  cells  to  cross-linking  agents  were  performed  without  knowing 
patients’  complementary  groups.  The  results  of  our  recent  work  have  shown  an  in  vivo 
prooxidant state of cells in FANCA and FANCD2 patients and clearly indicate that FA patients 
can be distinguished from idiopathic BMF patients based on the oxidant state of cells. Similar 
prooxidant state of cells was noted in female heterozygous carriers, but in none of the male I. JOKSIC et al: DEB-INDUCED SCE DISTINGUISH FA CELLULAR PHENOTYPE                                    395 
carriers  (PETROVIC  et  al.,  2011).  Knowing  that  the  DEB-associated  toxicities  involve  redox 
mechanisms, we analyzed DEB- induced SCE frequencies in FA patients and their mothers in 
order to ascertain whether or not that parameter can be used as an adjunct diagnostic tool for at 
least FANCA and FANCD2 complementation groups. In addition, frequencies of SCE induced 
by ionizing radiation are also examined. 
 
MATERIALS AND METHODS 
Study subjects. Subjects included in this study were twelve patients (six boys and six 
girls) with BMF of unknown etiology (non-FA BMF), five Fanconi anemia patients (one boy and 
four girls), and their parents. The patients were aged 8±5 years. Hematological parameters were 
within the range typical of bone marrow failure patients. Clinical diagnosis of FA was supported 
by  cellular  hypersensitivity  to  diepoxybutane  (AUERBACH,  2003).  The  FA  complementation 
group analysis (Universität Würzburg, Institut für Humangenetik, Germany and Department of 
Genetics Microbiology, Universitat Autonoma de Barcelona, Spain) showed that four patients 
(girls) belong to the complementation group FANCD2, whereas one patient (boy) belongs to the 
complementation  group  FANCA.  The  study  was  approved  by  the  Ethical  Committee  of  the 
Mother and Child Health Care Institute of Serbia, and parents of patients signed an informed 
consent regarding this investigation. A control group was consisted of twelve healthy volunteers 
with normal blood profiles. Peripheral blood samples were obtained in accordance with current 
Health and Ethical Regulations in Serbia.  
Blood cultures. Aliquots of heparinized whole blood (0.5 mL) of patients, their parents 
and controls were added to culture tubes containing 4.5 mL of a PBmax karyotyping medium 
(Invitrogen-Gibco, Paisley, UK). Three lymphocyte cultures from each subject were set up for 
assessment of sister-chromatid exchanges under different conditions of treatment: one culture 
served as a base-line control, the second one was treated with DEB, while the third was set up 
using irradiated peripheral blood samples.  
Sister chromatid exchange analysis. The SCE analysis was performed following the 
addition  of  5-bromo-2-deoxyuridine  (BrdUrd)  (Sigma  Chemicals  Co.,  Germany)  at  a  final 
concentration of 15 µg/mL to achieve sister chromatid
 differentiation. BrdUrd was added one 
hour after culture initiation, and cells were incubated for 72 hours; the last three hours in a 
presence of Colchicine (Sigma Chemicals Co., Germany) at a final concentration of 2.5 µg/mL. 
The cells were harvested and processed through treatments with a hypotonic solution (0.56% 
KCl) and fixative (3:1 methanol:glacial acetic acid). Differential staining of sister chromatids
 
was  performed  by  the  standard  fluorescence-plus-Giemsa  technique  (PERRY  and  WOLFF, 
1974).
  A  total  of  50  well-spread and  complete second-division metaphases  per culture  were 
scored for SCE using a Ziess-Axioplan2 microscope (Carl Zeiss, Jena, Germany). The frequency 
of SCE per cell was recorded. 
DEB  treatment.  Lymphocyte  cultures  were  treated  with  diepoxybutane  (Sigma 
Chemicals Co., Germany)  (final concentration 0.1µg/mL) one hour after culture initiation and 
incubated for 72 hours. 
Irradiation. Heparinized whole blood was irradiated using a 
60Co γ-ray source. The 
radiation  dose  employed  was  2  Gy,  the  dose  rate  was  0.45  Gy/min,  the  dimensions  of  the 
radiation field were 20 × 20 cm, and the distance from the radiation source was 74 cm. Aliquots 
of irradiated whole blood (0.5mL) were set up into cultures and incubated for 72 hours. 396                                                                                                             GENETIKA, Vol. 45, No.2,393-403, 2013 
Statistical  analysis.  A  statistical  analysis  was  carried  out  using  statistical  software 
package Statistics, version 6 for Microsoft Windows. Student’s t test was used, and the p value < 
0.05 was considered to be significant. 
 
RESULTS 
In  this  study,  we  analyzed  frequencies  of  SCE  in  lymphocytes  obtained  from  FA 
patients, non-FA BMF patients, their mothers, and healthy controls. Individual data of baseline, 
DEB-induced and radiation-induced frequencies of SCE are presented on Tables 1-3. The results 
of the current study showed that no significant difference in spontaneous frequencies of SCE 
between FA patients, non-FA BMF patients and healthy controls was observed (Table 4). The 
similar results were seen when mothers of FA and non-FA BMF patients, and control were 
analyzed.  
 
Table 1. The frequencies of SCE in lymphocytes of FA patients and their mothers. 
FA group  Patients  Baseline  DEB -induced  Radiation- 
induced 
Mothers 
of 
patients 
Baseline  DEB -
induced 
Radiation- 
induced 
FANCD2 
1  3.33±1.78  4.79±2.24  5.20±2.12  1a  3.83±1.62  3.96±1.65  5.30±2.19 
2  5.29±0.80  6.05±3.22  6.72±3.13  2a  3.71±1.78  5.65±2.06  6.78±1.73 
3  5.14±1.46  6.38±2.93  6.32±2.30  3a  4.00±2.16  6.00±1.97  6.70±1.75 
4  3.71±1.68  6.82± 2.77  6.20±2.80  4a  3.97±2.04  6.57±2.03  6.73±2.06 
FANCA  5  3.52±2.53  7.06±3.26  6.97±3.00  5a  3.78±2.03  5.45±2.34  6.40±2.76 
 
 
 
Table 2. The frequencies of SCE in lymphocytes of non-FA BMF patients and their mothers. 
 
 
non-FA 
BMF 
patients 
Baseline 
DEB -
induced 
Radiation- 
induced 
Mothers 
of 
patients 
Baseline 
DEB -
induced 
Radiation- 
induced 
6  3.80±2.05  6.71±2.37  5.38±3.58  6a  4.83±2.07  5.67±2.29  5.51±1.62 
7  3.87±2.62  7.50±2.72  5.32±2.93  7a  3.36±2.09  4.20±2.35  5.53±2.46 
8  4.06±2.29  3.57±3.10  5.97±2.73  8a  3.80±1.80  4.35±2.36  6.12±1.63 
9  5.06±2.84  3.93±3.67  6.94±3.26  9a  3.93±1.64  4.21±2.68  4.85±1.93 
10  3.70±2.05  3.57±1.78  5.69±2.45  10a  3.57±2.31  4.79±3.77  5.80±2.38 
11  3.91±2.47  3.81±2.45  5.35±2.88  11a  4.67±2.51  5.03±2.42  7.02±2.01 
12  4.97±2.59  3.64±2.18  5.84±2.05  12a  3.97±1.81  5.04±2.41  6.90±1.90 
13  5.54±2.93  4.65±2.46  5.87±2.86  13a  4.57±3.17  4.79±2.44  7.14±2.05 
14  3.13±1.3  4.16±2.27  6.19±2.15  14a  4.39±2.16  5.17±3.33  7.25±2.68 
15  3.41±2.71  1.81±0.88  6.63±2.29  15a  3.54±1.49  2.23±1.16  6.56±2.35 
16  2.79±2.45  2.07±1.79  6.09±2.04  16a  3.77±2.32  1.83±0.94  7.24±1.94 
17  3.30±1.62  2.86±1.90  5.50±2.28  17a  4.27±1.51  2.17±1.37  5.06±1.52 I. JOKSIC et al: DEB-INDUCED SCE DISTINGUISH FA CELLULAR PHENOTYPE                                    397 
Table 3. The frequencies of SCE in lymphocytes of healthy controls. 
 
 
 
Table 4. The baseline, DEB-induced and radiation-induced frequencies of SCE (mean ± S.D) in FA and 
non-FA BMF patients, their mothers, and healthy controls. 
 
*comparison with control, 
**comparison with non-FA BMF, ns- no significant 
 
 
However, in response to DEB FA patients displayed the highest frequency of SCE, over 
50%  higher  compared  to  both  non-FA  BMF  patients  and control,  and  48%  higher  than  the 
untreated self-control (p < 0.05)  (Figure 1).  
Control subjects  Baseline  DEB -induced  Radiation- induced 
18  4.90±3.07  4.43±1.39  5.29±2.63 
19  3.90±1.56  3.97±1.26  4.67±1.45 
20  3.07±1.37  2.27±1.29  3.97±1.61 
21  4.08±2.72  5.52±3.46  5.45±2.93 
22  4.87±2.06  4.26±2.78  4.85±1.82 
23  5.67±2.28  4.60±1.31  5.95±2.21 
24  6.27±2.54  5.67±3.64  6.67±2.44 
25  4.81±2.27  3.37±1.64  5.55±2.32 
26  3.19±1.31  2.13±1.32  5.95±1.58 
27  5.53±2.08  4.43±1.62  5.90±2.09 
28  4.25±2.12  3.19±1.62  5.53±2.24 
29  5.84±2.33  5.12±2.75  6.80±2.39 
 
Baseline 
frequency 
of SCE 
t test 
Frequency 
of  DEB –
induced SCE 
t test 
Frequency 
of   
radiation- 
induced SCE 
t test 
 
Control 
4.70±1.03  -  4.08±1.15  -  5.55±0.80  - 
FA patients  4.20±0.94 
*ns 
**ns 
6.22±0.89 
*p < 0.05 
**p < 0.05 
6.28±0.68
 
*ns 
**ns 
Mothers of FA 
patients 
3.86±0.12 
*ns 
**ns 
5.53±0.97 
*p < 0.05 
**p < 0.05 
6.38±0.62
 
*ns 
**ns 
non-FA BMF 
patients 
3.96±0.83 
*ns  4.02±1.66 
*ns  5.90±0.51
  *ns 
Mothers of  non-
FA BMF patients 
4.06±0.48 
*ns  4.12±1.30 
*ns  6.25±0.88
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The data  obtained  from  FA  female  carriers showed  the  similar  pattern  as  they  had 
significantly higher DEB-induced frequency of SCE compared to both mothers of non-FA BMF 
patients and control. In the same way, mothers of FA patients displayed 43% higher frequency of 
SCE compared to self-state before DEB treatment (p < 0.05).  
On the other hand, statistical analysis failed to show any significant differences in DEB-induced 
SCE  frequencies  in  non-FA  BMF  families.  The  frequency  of  DEB-induced  SCE  in  healthy 
controls  was  significantly  reduced  (p  <  0.05) compared  to  untreated  self-control  (Figure  1). 
Figure 2 shows metaphases displaying 13 SCE and asymmetrical chromatid exchange in FA 
cells treated with DEB. 
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Figure 1. The frequency of SCE induced by DEB and ionizing radiation (mean ± S.D) in FA and non-FA 
BMF patients, their mothers and controls. 
 
 
                       
                A                                         B     
Figure 2. Representative metaphases analyzed for SCE: (A) SCE at chromosomal termini, (B) incomplete 
asymmetrical exchange with chromatid gap in FANCD2 cell I. JOKSIC et al: DEB-INDUCED SCE DISTINGUISH FA CELLULAR PHENOTYPE                                    399 
Considering the radiation-induced SCE frequencies, excess values, significantly higher 
than the unirradiated self-controls are noted in all studied groups (Figure 1). However, there 
were no differences in SCE frequencies between patients and control. Comparable results were 
seen when mothers of FA and non-FA BMF patients, and control were analyzed (Table 4). 
The limited number of FANCA patients made it difficult to analyze complementation 
group-related differences in a base-line as well as in induced SCE frequencies. FANCA patient 
displayed slightly reduced baseline frequency of SCE compared to both FANCD2 patients and 
control. The frequencies of SCE induced by DEB and ionizing radiation in FANCA patient were 
modesty increased compared to frequencies observed in FANCD2 patients. 
 
DISCUSSION 
The role of the FANC protein network is both to promote translesion synthesis (TLS) at 
stalled/blocked  replication  forks  and  to  promote  homologous  recombination  (HR)  repair  at 
broken replication forks. A deficiency in the latter process could be expected to result in reduced 
spontaneous SCE in FA cells which is not observed (THOMPSON and HINZ, 2009). This finding 
suggests  that  there  is  more  than  one  pathway  of  HR  that  participates  in  restarting  broken 
replication forks. In agreement with that, in the current study, no differences in spontaneous 
frequencies  of  SCE  between  FA  patients,  non-FA  BMF  patients  and  healthy  controls  were 
observed.  
As mentioned before, studies on induced SCE in FA cells mostly suggest decreased 
SCE  frequencies  in  response  to  diepoxybutane.  However,  in  our  study  DEB-induced  SCE 
frequencies in FA patients and their mothers were significantly increased compared to both non-
FA BMF families and healthy controls. In control, progression of SCE in response to DEB is 
significantly suppressed, which is probably due to activity of RAD52 that increases the level of 
resistance to the cross-linking agents (PARK, 1995; JOHNSON et al., 1996).  
Diepoxybutane is a highly reactive compound. Upon epoxide hydrolysis, DEB can covalently 
bind to DNA bases. Likewise, DEB generates reactive oxygen species that, in turn, can either 
damage  DNA  or  produce  H2O2  (EREXSON  and  TINDALL,  2000).  The  fact  that  DEB  induces 
elevated frequency of SCE in FA patients and female carriers shedding new light on the redox-
dependent mechanisms in DEB toxicity, and suggests a direct association of oxidative stress with 
the primary genetic defect in FA, at least for complementation groups FANCA and FANCD2. 
DEB toxicity includes modulation of catalase and MnSOD activities, and glutathione depletion 
(PAGANO and KORKINA, 2000). In addition, DEB-sensitivity has been suggested to be due to the 
lack  of  glutathione  S-transferase  (GST)  T1  (LANDI  et  al.,  1996),  which  should  be  further 
examined  in  FA  patients.  It  has  been  reported  that  hypoxia  or  antioxidants  both  correct 
spontaneous as well as DEB-induced chromosomal instability. Moreover, catalase is specifically 
involved in DEB and MMC detoxification hence its defective expression is consistent with FA 
cell sensitivity to these agents  (KORKINA et al., 2000). The inefficient removal of peroxide can 
result in high rates of sister chromatid exchange  (NICOTERA et al., 1989). A recent study from 
our laboratory has shown that FA patients (FANCA and FANCD2) and their mothers display 
decreased catalase activity (PETROVIC et al., 2011), which may account for at least a part of the 
observed outcomes in the current study. In other words, the extensive chromosome aberrations 
often seen in FA cells may be results of increased DNA damage by excessive generation of ROS 
along with compromised DNA damage response processes linked to HR. 400                                                                                                             GENETIKA, Vol. 45, No.2,393-403, 2013 
The  finding  of  increased  SCE  suggests  inability  of  the  cell  to  repair  efficiently 
replication-blocking  lesions,  which  results  in  the  fork  collapse  and  the  initiation  of  HR.  In 
addition, defects in single strand break repair (SSBR) also lead to enhanced SCE frequencies, 
trough formation of double strand breaks upon a replication fork collapse at the SSB site, when 
HR than usually uses sister chromatid to facilitate accurate repair. In normal DNA replication, 
SCE occurs upon a natural fork collapse with estimates being 3-4 exchanges per cell per cycle. 
However, Thyagarajan and Campbell (THYAGARAJAN and CAMPBELL, 1997) reported that in FA 
fibroblasts  recombination  levels  are  nearly  100-fold  higher  than  that  in  controls,  which 
contribute  to  the  genomic  instability  and  cancer  predisposition  that  characterized  Fanconi 
anemia.  
The results  of the present study  showed  that in response to ionizing radiation SCE 
frequencies were significantly increased in all studied groups, but no differences between FA 
patients and non-FA BMF patients were seen. These results suggest that radiation-induced SCE 
frequencies cannot be used as a diagnostic tool for discrimination of FA in the large group of 
BMF patients.   
In conclusion, our data confirm and expand previous findings by showing that SCE 
induced by DEB can be used as an adjunct diagnostic test not only for FA patients, but also for 
female heterozygous carriers, at least for complementation groups FANCA and FANCD2.  
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Izvod 
Fankonijeva  anemija  (FA)  je  genetički  heterogena,  retka  bolest,  koju  karakterišu  razvojne 
anomalije, progresivna aplazija kostne srži i sklonost ka oboljevanju od karcinoma. Kliničke 
manifestacije bolesti u odredjenom satrosnom dobu, mogu biti veoma slične aplaziji kostne srži 
drugog  porekla.  Diferencijalna  dijagnostika  ove  dve  kategorije  uobičajeno  se  radi  testom 
indukcije hromozomskih aberacija alkilirajućim agensima, tzv. Diepoksibutan (DEB) testom na 
limfocitima  periferne  krvi  in  vitro,  ali  su  dragoceni  svi  drugi  testovi  koji  mogu  pomoći  u 
postavljanju  pravilne  dijagnoze.U  ovom  radu  prikazani  su  rezultati  ispitivanja  spontane  i 
indukovane  učestalosti  izmena  sestrinskih  hromatida  (SCE)  u  ćelijama  poreklom  od  FA 
pacijenata,  pacijenata  obolelih  od  aplazije  kostne  srzi,  njihovih  roditelja,  i  odgovarajućih 
kontrola.  Rezultati ispitivanja su pokazali da se bazalna učestalost izmena sestrinskih hromatida 
ne  razlikuje  izmedju  tri  navedene  grupe.  Tretman  DEB-om,  u  trajanju  od  24h    finalne 
concentracije  0.1µg/ml  indukuje  dvostruko  povećanje  učestalosti  SCE  samo  u  grupi  FA 
pacijenata i njihovih majki. Iznenadjujuće je da se heterozigotni nosioci mutacije u FA genima 
ženskog  pola  (majke),  in  vitro,  po  učestalosti  SCE  ne  razlikuju  od  homozigotnih  nosilaca 
mutacije. Ćelije poreklom od pacijenata sa drugim uzrokom aplazije kostne srži ponašaju se 
slično  kontrolnim.  Učestalost  SCE  u  in  vitro  ozračenim  uzorcima  krvi  navedenih  grupa,  ne 
pokazuje  statistički  značajnu  razliku.  Na  osnovu  dobijenih  rezultata  može  se  zaključiti  da 
indukovana učestalost SCE alkilirajućim agensima može da bude od značaja kao dodatni test u 
diferencijalnoj dijagnostici FA ćelijkog fenotipa.  
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